Sou Hu Cai Jing·2025-04-28 11:40Group 1 - The core viewpoint of the news is that WuXi AppTec's stock price has reached a new low in 17 days, with a closing price of 58.09 yuan and a rolling PE ratio of 17.75 times, significantly lower than the industry average [1] - As of the first quarter of 2025, a total of 383 institutions hold shares in WuXi AppTec, with 378 being funds, totaling 1,109,788,100 shares and a market value of 74.711 billion yuan [1] - WuXi AppTec's main business is providing integrated, end-to-end drug research and development services for the global pharmaceutical and life sciences industry, with key products including chemical, testing, and biological services [1] Group 2 - In the first quarter of 2025, WuXi AppTec reported a revenue of 9.655 billion yuan, representing a year-on-year increase of 20.96%, and a net profit of 3.672 billion yuan, reflecting a year-on-year increase of 89.06%, with a gross profit margin of 42.26% [1] - The average PE ratio for the medical services industry is 40.74 times, with a median of 42.36 times, placing WuXi AppTec at the 17th position in the industry ranking [2] - The total market capitalization of WuXi AppTec is 167.763 billion yuan [2]